Profile: Dr. Kevin Moore
by Nicole Johns
by Nicole Johns
Sept. 20, 2019
Dr. Moore is our first guest to fill out our speaker questionnaire. We hope that these profiles allow the community to learn more about the people doing the work to End the HIV Epidemic in our region.
Dr. Moore visited with the Positive Committee on Tuesday, September 10th to talk about the treatment for substance use disorder. With Dr. Moore's assistance, the Positive Committee unpacked common stereotypes about people who use heroin and other opioids and explored how those stereotypes are harmful and stigmatizing to drug users. He also shared information about medication-assisted treatment (MAT) for opioid use disorder. Medication-assisted treatment (MAT) is the use of medications with counseling and behavioral therapies to treat substance use disorders and prevent opioid overdose.
Name: Dr. Kevin Moore
Affiliation: Courage Medicine
What is something you wished more people understood about your area of expertise?
That behavioral healthcare is basic healthcare and not special treatment because rich people's feelings are more important.
What will be the main theme of your presentation?
How stigma against people with addictions impacts their ability to get care.
What excites you about your work?
Helping as much and as many people as I can.
What's something you love about the Philadelphia region?
You can hear more from Dr. Moore on this episode of the Shrinks on Third podcast (20 min) where he discusses his passion for integrative medicine for vulnerable populations, specifically people with opioid dependency. Dr. Moore is a co-author of the book: Integrative Medicine for Vulnerable Populations: A Clinical Guide to Working with Chronic and Comorbid Medical Disease, Mental Illness, and Addiction to be published in 2020.
You can learn more about medication-assisted treatment at SAMHSA's website.
This website is supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) as part of an award totaling $20,808,001. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by HRSA, HHS, or the U.S. Government. For more information, please visit HRSA.gov.